The CFAR Molecular Core will provide CFAR investigators with the molecular biological regents and tools necessary to pursue their research by serving as a repository for expression vectors, antibodies and antisera, cell lines, and viral vectors. In addition to its role as a reagent repository, the Molecular Core will provide advice and expertise to investigators on such topics as the cloning and manipulation of genes and the functional analysis of viral proteins such as Env. Importantly, the Molecular Core will interface closely with the Virology Core. Viral genes will be isolated from primary viruses that are of interest to CFAR investigators and that are provided by the Virology Core, and placed into appropriate vectors. High level expression vectors will then be provided, when requested, to the Structural Core for large-scale production of gene products. The Molecular Core will also interact directly with the Clinical Core by genotyping patient samples for polymorphisms associated with altered disease progression. Thus, by consolidating and making available important reagents, by providing technical advance, by genotyping patient samples, and though the construction of expression systems the Molecular Core will facilitate interactions between the Virology, Clinical, and Structural Cores and will assist investigators in their research efforts. In addition, the Molecular Core will help foster collaborations and help draw new and established investigators into HIV/SIV research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI045008-02
Application #
6327582
Study Section
Project Start
2000-07-15
Project End
2001-06-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
$165,421
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Knecht, Vincent R; McGinniss, John E; Shankar, Hari M et al. (2018) Molecular analysis of bacterial contamination on stethoscopes in an intensive care unit. Infect Control Hosp Epidemiol :1-7
Vujkovic, Marijana; Bellamy, Scarlett L; Zuppa, Athena F et al. (2018) Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana. Pharmacogenomics J 18:678-688
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Grover, Surbhi; Bvochora-Nsingo, Memory; Yeager, Alyssa et al. (2018) Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. Int J Radiat Oncol Biol Phys 101:201-210
Crits-Christoph, Paul; Gallop, Robert; Noll, Elizabeth et al. (2018) Impact of a medical home model on costs and utilization among comorbid HIV-positive Medicaid patients. Am J Manag Care 24:368-375
Sherrill-Mix, Scott; McCormick, Kevin; Lauder, Abigail et al. (2018) Allometry and Ecology of the Bilaterian Gut Microbiome. MBio 9:
Kadimisetty, Karteek; Song, Jinzhao; Doto, Aoife M et al. (2018) Fully 3D printed integrated reactor array for point-of-care molecular diagnostics. Biosens Bioelectron 109:156-163
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Fraietta, Joseph A; Nobles, Christopher L; Sammons, Morgan A et al. (2018) Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558:307-312
Kelly, Matthew S; Surette, Michael G; Smieja, Marek et al. (2018) Pneumococcal Colonization and the Nasopharyngeal Microbiota of Children in Botswana. Pediatr Infect Dis J 37:1176-1183

Showing the most recent 10 out of 775 publications